Source - SMW
Venn Life Sciences said subsidiary Venn Life Sciences Ltd has entered into a conditional agreement under which it and Lynchwood Nominees Ltd, as custodian for the Helium Rising Stars Fund, would sell the entire issued share capital of Innovenn UK Ltd for a total of up to £4.74m.